| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Loss on assets held for sale | - | 0 | -12,200 | - |
| Total other income (expense), net | -18,900 | -18,400 | 42,800 | 77,900 |
| Income (loss) before income taxes | 57,600 | -16,800 | 92,700 | 142,400 |
| Income tax provision | 6,400 | -4,800 | 24,700 | 27,600 |
| Net income (loss) | 51,200 | -12,000 | 68,000 | 114,800 |
| Basic (in dollars per share) | 0.96 | -0.22 | 1.25 | 2.16 |
| Basic (in shares) | 53,200,000 | 54,200,000 | 54,400,000 | 53,100,000 |
| Diluted (in dollars per share) | 0.91 | -0.22 | 1.19 | 2.06 |
| Diluted (in shares) | 56,500,000 | 54,200,000 | 57,300,000 | 55,600,000 |
Emergent BioSolutions Inc. (EBS)
Emergent BioSolutions Inc. (EBS)